Tom Pike is chairman of this company. Mr. Pike is actively involved with a number of life science companies and organizations in the capacity of consultant and/or board member. His past experience range from and Chairman & CEO of Clavis Pharma ASA, a public oncology drug development company to Partner of the venture capital group NeoMed Management and more than 18 years’ experience as CEO, sales and marketing director, business alliance manager and other positions at Hoffmann-La Roche in Switzerland and Norway. He has served on the board (past Chairman) of the Norwegian Association of Pharmaceutical Manufacturers for six years. Mr. Pike is a Norwegian and British citizen and holds a B.Sc. Honours in Pharmacology.
Haematology